Special clinical nutritional formulation for AIDS (Acquired Immune Deficiency Syndrome) and preparation method thereof

A nutritional formula and special-purpose technology, applied in the field of clinical nutritional formula, can solve the problems of strong toxic and side effects of drugs, long-term use of drugs, lack of nutritional assistance in clinical treatment, etc., and achieve the effect of slowing down immunological abnormalities

Inactive Publication Date: 2019-03-22
上海奥医生物医药科技有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the enteral nutrition preparation of this patent is only used to provide routine nutritional support for AIDS patients to improve the nutritional status of patients and enhance the immunity of patients, and does not have the function of nutritional assistance in clinical treatment
[0015] At present, the drug preparations for AIDS are mainly virus blocking drugs and anti-viral replication drugs taken within 72 hours. There are still the following problems: 1. The toxic and side effects of the drugs are relatively strong; 2. The drugs need to be taken for a long time. There are no targeted products for the consumption of various nutrients that can support and supplement the body; 3. There is no nutritional supplement that can provide targeted nutritional support and symptom relief for the clinical manifestations of AIDS.
[0016] Therefore, the development of a clinical nutrition product that can fill the gap that is not yet clear can alleviate the side effects and adverse reactions of anti-HIV drugs, alleviate and improve the corresponding symptoms of AIDS from the perspective of pathogenesis, and at the same time enhance the patient's self-immunity , the clinical nutritional formula for repairing the patient's autoimmune barrier and preventing opportunistic infection has important value and a broad market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0082] The AIDS-specific clinical nutritional formula of the present invention includes 10g of soybean peptide powder, 10g of hydrolyzed whey protein, 10g of soybean protein isolate, 1g of bovine colostrum powder, 130mg of taurine, 10g of medium-chain triglyceride microcapsule powder, purple Su seed oil microcapsule powder 5g, rock sugar 17.7g, maltodextrin 10g, fructooligosaccharides 6g, inulin 9.3g, calcium 551mg, iron 16.8mg, zinc 13.08mg, selenium 23μg, copper 257μg, vitamin A 1117μg, β- Carotene 15μg, Vitamin D 3 1.8μg, vitamin E 15.92mg, vitamin B 1 1.98mg, vitamin B 2 1.49mg, vitamin B 6 1.98mg, vitamin B 12 5.01μg, Vitamin C 197.7mg, Pantothenic Acid 5.92mg, Niacin 29.58mg, Folic Acid 821μg, Grifola frondosa 1g, Bitter Melon Powder 1g, Garlic Powder 1g, Carrot Powder 1g, Bitter Almond 1g, Polygonatum 0.5g, Hawthorn 0.5g, Water Silybum thistle seed oil 2g, oat β-glucan 0.5g, Cordyceps militaris 0.5g, phosphatidylserine 0.1g.

Embodiment 2

[0084] The AIDS-specific clinical nutritional formula of the present invention includes 10g of soybean peptide powder, 10g of hydrolyzed whey protein, 10g of soybean protein isolate, 1g of bovine colostrum powder, 130mg of taurine, 10g of medium-chain triglyceride microcapsule powder, purple Su seed oil microcapsule powder 5g, rock sugar 17.7g, maltodextrin 12.7g, fructooligosaccharides 6g, inulin 9.3g, calcium 551mg, iron 16.8mg, zinc 13.08mg, selenium 23μg, copper 257μg, vitamin A 1117μg, β -Carotene 15μg, vitamin D3 1.8μg, vitamin E 15.92mg, vitamin B11.98mg, vitamin B21.49mg, vitamin B61.98mg, vitamin B125.01μg, vitamin C 197.7mg, pantothenic acid 5.92mg, niacin 29.58mg, folic acid 821μg, Grifola frondosa 1g, Bitter melon powder 0.1g, Garlic powder 0.1g, Carrot powder 0.1g, Bitter almond 0.1g, Polygonatum 0.1g, Hawthorn 0.1g, Milk thistle seed oil 2g, Oat β-glucan 0.5g , Cordyceps militaris 0.5g, phosphatidylserine 0.1g.

Embodiment 3

[0086] The AIDS-specific clinical nutritional formula of the present invention includes 10g of soybean peptide powder, 10g of hydrolyzed whey protein, 10g of soybean protein isolate, 1g of bovine colostrum powder, 130mg of taurine, 10g of medium-chain triglyceride microcapsule powder, purple Su seed oil microcapsule powder 5g, rock sugar 17.7g, maltodextrin 14.8g, fructooligosaccharides 6g, inulin 9.3g, calcium 551mg, iron 16.8mg, zinc 13.08mg, selenium 23μg, copper 257μg, vitamin A 1117μg, β -Carotene 15μg, vitamin D3 1.8μg, vitamin E 15.92mg, vitamin B11.98mg, vitamin B21.49mg, vitamin B61.98mg, vitamin B125.01μg, vitamin C 197.7mg, pantothenic acid 5.92mg, niacin 29.58mg, folic acid 821μg, Grifola frondosa 0.1g, Bitter melon powder 1g, Garlic powder 1g, Carrot powder 1g, Bitter almond 1g, Polygonatum 0.5g, Hawthorn 0.5g, Milk thistle seed oil 0.2g, Oat β-glucan 0.1g, Pupa Cordyceps 0.1g, phosphatidylserine 0.01g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a special clinical nutritional formulation for AIDS (Acquired Immune Deficiency Syndrome). The special clinical nutritional formulation is prepared from the following componentsin parts by weight: 23 to 32 parts of protein, 13 to 17 parts of fat, 27 to 40 parts of carbohydrate, 10 to 20 parts of dietary fiber, 0.4 to 0.7 part of macro elements, 0.01 to 0.04 part of trace elements, 0.005 to 0.02 part of fat soluble vitamin, 0.1 to 0.25 part of water-soluble vitamin, 0.1 to 4 parts of dietary essence, 0.2 to 2 parts of medicinal and edible ingredients and 0.05 to 4 partsof new resource food. The invention also provides a preparation method of the clinical nutritional formulation. The clinical nutritional formulation provided by the invention has the advantages that the toxic and side effects and adverse reactions of anti-AIDS drugs can be alleviated; corresponding symptoms of the AIDS are relieved from the pathogenesis; the autoimmunity barrier of patients is repaired and the occurrence of opportunistic infection is prevented, so that nutritional auxiliary functions of the special clinical nutritional formulation in clinical treatment are realized.

Description

technical field [0001] The invention relates to the field of clinical nutritional formulas, in particular to an AIDS-specific clinical nutritional formula and a preparation method thereof. Background technique [0002] AIDS, the full name of acquired immunodeficiency syndrome, is a sexually transmitted disease (STD) caused by human immunodeficiency virus infection and characterized by severe immunodeficiency. Clinically, it is characterized by lymphadenopathy, anorexia, chronic diarrhea, weight loss, Onset of systemic symptoms such as fatigue, and gradually developed to various opportunistic infections, secondary tumors, etc. and died. AIDS spreads quickly and has a high fatality rate. Currently, there is no effective cure, and it has become one of the major fatal infectious diseases for human beings. [0003] AIDS (HIV) can be divided into type 1 (HIV-1) and type 2 (HIV-2) according to serotype, among which HIV-1 is the main epidemic type of AIDS, and HIV-2 is mainly limit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A23L33/00A23L33/21A23L33/16A23L33/15A23L31/00A23L33/10A23L33/19A23L33/115A23L33/125A23L33/175A23L33/185A23L33/18A23L33/155
CPCA23L31/00A23L33/10A23L33/115A23L33/125A23L33/15A23L33/155A23L33/16A23L33/175A23L33/18A23L33/185A23L33/19A23L33/21A23L33/40A23V2002/00A23V2200/324A23V2200/308A23V2200/32A23V2200/30A23V2250/55A23V2250/5488A23V2250/54252A23V2250/5424A23V2250/54248A23V2250/5428A23V2250/0644A23V2250/0618A23V2250/0606A23V2250/062A23V2250/065A23V2250/0654A23V2250/0626A23V2250/0628A23V2250/1944A23V2250/5114A23V2250/5116A23V2250/5112A23V2250/5066A23V2250/5062A23V2250/28A23V2250/1592A23V2250/16A23V2250/1642A23V2250/1614A23V2250/1588A23V2250/1586A23V2250/1612A23V2250/1626A23V2250/702A23V2250/7106A23V2250/712A23V2250/7142A23V2250/7042A23V2250/7044A23V2250/7052A23V2250/706A23V2250/708A23V2250/705A23V2250/7056A23V2250/1852
Inventor 尤俊季敬东
Owner 上海奥医生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap